2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
Ein Dokument
mehr
Storys zum Thema Genetik
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
mehrEleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produce difficult-to-express but therapeutically promising drug candidates. Its recently expanded production ...
mehrTechnische Universität München
A protein causes higher risk of severe cancer progression for men
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36939 High resolution images: https://mediatum.ub.tum.de/1631416 NEWS RELEASE Cause found for higher sex-specific risk of mortality A protein causes significantly higher risk of severe cancer progression for men A ...
mehrTechnische Universität München
The proteins of Covid-19: machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36913 High resolution images: https://mediatum.ub.tum.de/1624573 NEWS RELEASE The proteins of Covid-19 ...
mehrEleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-art, 500 l single-use reactors from Sartorius Stedim Systems. The scale-up will enable Eleva to enter ...
mehrTechnische Universität München
Messengers from gut to brain
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36901 High resolution images: https://mediatum.ub.tum.de/1622134 NEWS RELEASE Messengers from gut to brain Seen for the first time: T cells traveling from the gut and skin to the central nervous system Scientists have long been aware of a link between the gut ...
mehrGold Standard Diagnostics Europe
Novatec and Virotech to become Gold Standard Diagnostics Europe
Dietzenbach (ots) - The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to ...
mehrTechnische Universität München
New approach identifies T cells in Covid-19 patients
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36882/ NEWS RELEASE New approach identifies T cells in Covid-19 patients Immune cell profile reveals appearance, number and activity level against SARS-CoV-2 T cells play a decisive role in fighting the ...
mehrLebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic deramatitis in two Phase 3 trials
Barcelona (ots/PRNewswire) - - Primary and all key secondary endpoints including itch, interference of itch on sleep and quality of life were met at Week 16 in two pivotal Phase 3 trials - Safety profile consistent with prior lebrikizumab studies in atopic dermatitis Lebrikizumab led to significant improvements with ...
mehrTechnische Universität München
Taking aim at skin bacteria
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36873/ Video: https://youtu.be/qMsYJGqJLlQ NEWS RELEASE Taking aim at skin bacteria Enzyme treatment of skin samples improves microbiome analysis Healthy skin has a bacterial shield to protect against germs: the microbiome. This complex assembly of microorganisms ...
mehrTechnische Universität München
Domestication of plants adds to the range of available food
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36841/ High resolution images: https://mediatum.ub.tum.de/1619885 NEWS RELEASE More diversity for our farms and forks Domestication of plants adds to the range of available food As a contribution to increasing crop variety for improved food ...
mehrTechnische Universität München
The virus trap: hollow nano-objects made of DNA could trap viruses and render them harmless
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36810/ High resolution images: https://mediatum.ub.tum.de/1616943 NEWS RELEASE The virus trap Hollow ...
mehr- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
Ein Dokumentmehr Technische Universität München
At what temperature the weather becomes a problem - Climate change leads to increasing heat strain for humans, animals and crops
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36780/ High resolution images: https://mediatum.ub.tum.de/1616096 A t what temperature the weather becomes a problem Climate change leads ...
mehr- 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
Ein Dokumentmehr Gastrulation research reveals novel details about embryonic development
mehrTechnische Universität München
Versatile, fast and reliable: new automated microarray rapid test detects SARS-CoV-2 antibodies
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36762/ High resolution images: https://mediatum.ub.tum.de/1615381 NEWS RELEASE Versatile, fast and reliable SARS-CoV-2 antibody assay Automated microarray ...
mehr- 2
Plant Protector: How plants strengthen their light-harvesting membranes against environmental stress
mehr Technische Universität München
Animal health through genomics | Feasibility study: Preventing diseases through genome analysis and genome scissors
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36757/ High resolution images: https://mediatum.ub.tum.de/1615373 Animal health through genomics Feasibility study: Preventing diseases ...
mehrSysmex Inostics presents data at ASCO
Baltimore, MD (ots) - Sysmex Inostics presents data at ASCO showing HPV-SEQ, a new CLIA-validated SafeSEQ NGS HPV16/18 liquid biopsy assay, is highly effective for measuring HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. Sysmex Inostics, Inc., a global leader in the liquid biopsy revolution for oncology, is presenting the poster ...
mehrInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
mehrDid my vaccine work? New rapid test for the determination of vaccination success
mehrTechnische Universität München
Four ERC Advanced Grants for TUM scientists
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36588/ NEWS RELEASE EU funding for cutting-edge research Four ERC Advanced Grants for TUM scientists Artificial viruses made with DNA. The human lung as a computer model. A new approach to research on diseases ...
mehrTechnische Universität München
Biomass production by reverse citric acid cycle - central metabolic pathway runs "backwards" at high carbon dioxide concentrations
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36584/ Image: ...
mehr- 2
Lindis Biotech develops immunotherapy against bladder cancer
Ein Dokumentmehr Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients
Baltimore, MD, USA (ots) - Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster “Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients” at the 112th Annual Meeting of the American Association for Cancer ...
mehrFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
mehrOrigenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins
Ein Dokumentmehr- 4
ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies
Ein Dokumentmehr
Vorherige1234567Nächste